What is the recommendation for evaluation and treatment to improve long-term adherence, considering a social work or psychology (psych) consultation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

I strongly recommend a social work and/or psychology consultation to develop a comprehensive adherence plan for this patient, as it is crucial for improving long-term health outcomes by addressing complex psychosocial factors that may interfere with treatment adherence. The consultation should be arranged promptly to establish a supportive framework for medication and treatment compliance. According to the 2021 update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment 1, a patient-centered approach that considers the patient's perspective, simplifies medication regimens, and addresses costs and access can improve adherence. The social worker or psychologist can assess barriers to adherence, including psychological factors, social determinants, financial constraints, and health literacy issues, and implement targeted interventions such as motivational interviewing, cognitive behavioral therapy techniques, or connection to community resources. Regular follow-up sessions should be scheduled, initially more frequently (perhaps weekly or biweekly), then adjusting based on progress. This approach is supported by the EASL clinical practice guidelines: liver transplantation, which recommends social, psychological, and psychiatric evaluation to evaluate adherence and potential risk factors for non-adherence after liver transplantation 1. However, the more recent and higher-quality study by the American College of Cardiology 1 provides a more comprehensive framework for improving adherence, emphasizing the importance of a patient-centered approach and the use of decision aids, education, and behavioral supports to promote adherence.

Some key considerations for the social work and/or psychology consultation include:

  • Assessing the patient's goals and values to inform the development of a personalized adherence plan
  • Identifying and addressing potential barriers to adherence, such as depression, anxiety, or substance use
  • Providing education and support to promote health literacy and self-management skills
  • Facilitating access to community resources and services to support adherence and overall well-being
  • Monitoring progress and adjusting the adherence plan as needed to ensure optimal outcomes.

By prioritizing a patient-centered approach and addressing the complex psychosocial factors that influence adherence, we can improve long-term health outcomes and reduce the risk of non-adherence and its associated consequences.

From the Research

Evaluation and Treatment Recommendations

The recommendation for social work/psych consult may be helpful for long-term adherence planning is supported by several studies.

  • A study published in 2014 2 found that complex interventions with multiple components, including tailored ongoing support from allied health professionals, can improve medication adherence.
  • Another study published in 2020 3 highlighted the importance of interaction with a health professional in promoting adherence and understanding the reasons for non-adherence.
  • A review of interventions to improve medication adherence published in 2018 4 identified six categories of interventions, including patient education, medication regimen management, and clinical pharmacist consultation, which can be effective in improving adherence.

Key Factors in Medication Adherence

Several factors can affect medication adherence, including:

  • Patient-related factors such as health literacy and involvement in treatment decision-making 5
  • Physician-related factors such as prescription of complex drug regimens and communication barriers 5
  • Health care system-related factors such as office visit time limitations and limited access to care 5
  • A study published in 2021 6 found that unintentional non-adherence, such as forgetting to take medications or running out of medications, is a common issue among patients with chronic illnesses.

Strategies for Improving Medication Adherence

Several strategies can be used to improve medication adherence, including:

  • Using combination pills to reduce daily pill burden 4
  • Clinical pharmacist consultation for disease co-management 4
  • Medication-taking reminders such as telephone calls to prompt refills 4
  • Patient education and counseling 4
  • A study published in 2011 5 suggested that multifactorial solutions are needed to address the complex and varied barriers to medication adherence.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Interventions for enhancing medication adherence.

The Cochrane database of systematic reviews, 2014

Research

Medication adherence: understanding the issues and finding solutions.

British journal of community nursing, 2020

Research

Medication adherence: WHO cares?

Mayo Clinic proceedings, 2011

Related Questions

What additional information is needed to guide interventions for a patient with elevated Hemoglobin A1C (HbA1C) of 9.2%, polydipsia, and polyuria?
What are common medications prescribed to enhance treatment effects for various diseases?
What is the best course of action for a 56-year-old female with a history of anxiety, gout, and depression, currently taking Duloxetine, Bupropion, Gabapentin, Cymbalta (Duloxetine), and Buspar (Buspirone), who reports a slight increase in anxiety due to life situations and requests a dose increase of Buspar?
How should new findings from the Traverse study be incorporated into clinical practice?
What should be done if a patient with atrial fibrillation is not taking their prescribed medications, including Flecainide (flecainide), Metoprolol (metoprolol), and Eliquis (apixaban)?
What is the significance of a Urinary Tract Infection (UTI) that is positive for nitrites and negative for Leukocyte Esterase (leuk est)?
What is the treatment for a 20-week pregnant female with acute pyelonephritis (infection of the kidney) and fever?
What is the management of sigmoid sinus thrombosis (SST)?
What is the diagnosis for a 2-year-old male with a history of congenital hydronephrosis, Patent Ductus Arteriosus (PDA) and Patent Foramen Ovale (PFO), presenting with a 1-day history of vomiting and diarrhea, without fever, and a urinalysis showing positive nitrites and negative leukocyte esterase?
What is the etiology of markedly elevated alkaline phosphatase (ALP) level in the setting of resolving pancreatitis?
What medications can cause an increase in Alkaline Phosphatase (ALP) levels?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.